David A. Siegel Cidara Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 23,900 shares of CDTX stock, worth $303,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,900

Previous 40,400 40.84%

Holding current value

$303,291

Previous $31,000 32.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.64 - $0.92 $10,560 - $15,180	-16,500 Reduced 40.84%	23,900 $21,000
Q4 2023 Feb 14, 2024	SELL	$0.68 - $0.97 $10,064 - $14,356	-14,800 Reduced 26.81%	40,400 $31,000
Q3 2023 Nov 14, 2023	SELL	$0.77 - $1.16 $16,478 - $24,824	-21,400 Reduced 27.94%	55,200 $51,000
Q2 2023 Aug 14, 2023	BUY	$1.01 - $1.42 $13,130 - $18,460	13,000 Added 20.44%	76,600 $86,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.98 $28,350 - $74,844	37,800 Added 146.51%	63,600 $80,000

Q4 2022 Feb 14, 2023	SELL	$0.48 - $0.76 $1,152 - $1,824	-2,400 Reduced 8.51%	25,800 $19,000
Q3 2022 Nov 14, 2022	SELL	$0.45 - $0.81 $4,722 - $8,500	-10,494 Reduced 27.12%	28,200 $18,000
Q2 2022 Aug 15, 2022	SELL	$0.43 - $0.91 $49,751 - $105,287	-115,700 Reduced 74.94%	38,694 $19,000
Q1 2022 May 16, 2022	SELL	$0.67 - $1.39 $262,573 - $544,741	-391,900 Reduced 71.74%	154,394 $129,000
Q4 2021 Feb 14, 2022	BUY	$1.18 - $2.18 $91,686 - $169,386	77,700 Added 16.58%	546,294 $694,000
Q3 2021 Nov 15, 2021	BUY	$1.48 - $2.35 $633,440 - $1.01 Million	428,000 Added 1054.34%	468,594 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$1.87 - $2.7 $90,134 - $130,140	-48,200 Reduced 54.28%	40,594 $82,000
Q1 2021 May 17, 2021	BUY	$2.06 - $3.01 $111,528 - $162,961	54,140 Added 156.23%	88,794 $236,000
Q4 2020 Feb 16, 2021	SELL	$1.99 - $3.25 $33,312 - $54,405	-16,740 Reduced 32.57%	34,654 $69,000
Q3 2020 Nov 16, 2020	SELL	$2.85 - $4.1 $103,341 - $148,666	-36,260 Reduced 41.37%	51,394 $146,000
Q2 2020 Aug 14, 2020	BUY	$2.39 - $4.0 $121,412 - $203,200	50,800 Added 137.84%	87,654 $323,000
Q1 2020 May 15, 2020	BUY	$1.74 - $4.26 $39,765 - $97,358	22,854 Added 163.24%	36,854 $91,000
Q4 2019 Feb 14, 2020	BUY	$1.77 - $3.84 $24,780 - $53,760	14,000 New	14,000 $54,000

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.1M

Call Options Held

2.7K

Put Options Held

100

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account